Data Integrity Inspections Go Global
This article was originally published in Scrip
As FDA and other regulatory authorities learn how to conduct the type of inspections that have put a spotlight on data integrity failures in India, they warn that no manufacturer, no matter where they’re located, is immune from this potentially devastating issue. Bowman Cox, editor of "The Gold Sheet" reports.
You may also be interested in...
Alkermes CRL is just the latest fallout from black-hole process.
Letter of authorization for COVID-19 therapeutic made at troubled Lilly plant requires independent third-party oversight.
Prospective new participants in benchmarking study must share manufacturing plant data by 20 November to see how they measure on quality against industry peers.